Translate this page into:
Epidemiology of vitamin D deficiency in West African hemodialysis patients: A pilot study from Senegal
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Sir,
Vitamin D deficiency is common in chronic kidney disease patients undergoing hemodialysis and is associated with bone disorders[1] and increased mortality.[2] Previous studies suggest that vitamin D deficiency is more frequent in patients with an African origin whose skin pigmentation is a barrier to ultraviolet rays necessary to 25-OH vitamin D synthesis.[13] Like in many developing regions, little is currently known about vitamin D status of dialysis patients from Sub-Saharan Africa.[4] Data from black populations living in the United States or Europe might not be applicable for African patients whose dietary habits and sunlight exposures are different. We report here a pilot study that aimed to determine the prevalence of vitamin D deficiency in Senegalese hemodialysis patients.
In a cross-sectional study between March 30th and October 30th 2011, we included 46 patients from two main hemodialysis centers in Dakar. Clinical data, serum calcium, phosphate and vitamin D levels during the last 3 months were collected from patients’medical records. All dosages of 25-OH vitamin D were performed using electrochemiluminescence immunoassay (COBAS Roche Diagnostics). Vitamin D deficiency was defined as a serum 25-OH vitamin D level <15 μg/l. Univariate and multivariate logistic regressions were used to identify the factors associated with vitamin D deficiency.
Mean age of patients was 50.3 ± 12.7 years (13-77 years) and 39.1% of them were females. All patients were dialyzed using the bicarbonate buffer and a calcium rich dialysate (1.75 mmol/l). Almost all of them (91%) had a weekly Kt/V >1.2. Thirty six patients (78.2%) presented pre-dialysis high blood pressure (≥140/90 mmHg) and six patients (13%) had a body mass index above 30 kg/m2. The etiologies of end-stage renal disease were dominated by hypertension (39%) and diabetes (26%).
Prevalence of vitamin D deficiency was 32.6% and 28 patients (60.8%) had a vitamin D level between 15 μg/Land 30 μg/l). This prevalence was comparable between men and women (respectively 47.3% and 50.0%, P = 0.93). After multivariate logistic regression, age ≥50 years, hypocalcemia and hyperparathyroidism showed significant association of vitamin D deficiency, but gender and hyperphosphatemia did not [Table 1].
The present results show that the prevalence of vitamin D deficiency in hemodialysis patients living in Senegal is similar to those reported in Western countries.[135]
Despite limitation due to small sample size and the cross-sectional study design, this study could be a basis for larger prospective cohort that would also assess the effect of vitamin D deficiency on bone and cardiovascular outcomes in African dialysis patients.
References
- Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis. 2011;58:544-53.
- [Google Scholar]
- Vitamin D status and mortality risk in CKD: Ameta-analysis of prospective studies. Am J Kidney Dis. 2011;58:374-82.
- [Google Scholar]
- Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012;82:84-9.
- [Google Scholar]
- Mineral and bone disease in black African hemodialysis patients: A report from Senegal. Nephrourol Mon. 2012;4:613-6.
- [Google Scholar]
- Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr. 2008;18:395-9.
- [Google Scholar]
